Retiro De Equipo (Recall) de Multiple AxiEM ENT Suction Instruments Straight Suction EM, ENTCurved Suction 70 EM, Short Curved Suction 90, EM Suction Small Straight AxiEM ENT

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Medtronic Australasia Pty Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    RC-2017-RN-00861-1
  • Clase de Riesgo del Evento
    Class I
  • Fecha de inicio del evento
    2017-07-12
  • País del evento
  • Fuente del evento
    DHTGA
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Medtronic has become aware that the specific lots of axiem ent suction instruments are not able to pass instrument verification. instrument verification is a step in the software which is performed prior to the use of each instrument. this verification step confirms device tracking functionality and prevents use of the device if a passing verification is not achieved. the impacted devices were made with a particular stainless steel stock material that exhibits magnetic characteristics (magnetic permeability), causing interference with electromagnetic (em) tracking capability of the stealthstation.If this issue presents during surgery, it may result in surgery being extended to troubleshoot the issue, discontinuation of navigation, or aborting surgery if alternative instruments are not available to proceed. to date, there have been no reports of patient injury.
  • Acción
    Medtronic is requesting customers examine their inventory and if any of the affected products listed in the customer letter are found, immediately cease use and quarantine them for return to Medtronic. Alternatively, each local Medtronic Sales Representative will perform this step. If the product has been removed from its original packaging, the part number and lot number can be found printed directly on the device as shown in the pictures given in the customer letter.

Device

  • Modelo / Serial
    Multiple AxiEM ENT Suction InstrumentsStraight Suction EM, ENTCurved Suction 70 EM, Short Curved Suction 90, EM Suction Small Straight AxiEM ENTMultiple Part and Lot NumbersThese instruments may also be included in the following kits:ENT Instrument SetFusion ENT Instrument KitENT AxiEM Instrument SetENT Prgm Add Fusion Nav AxiEMARTG Numbers: 129428, 125074 & 120114
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA